How do I interpret a fractionated alkaline phosphatase (ALP) result?

How to Interpret Fractionated Alkaline Phosphatase Results

Measure γ-glutamyl transpeptidase (GGT) alongside total ALP to determine tissue origin: elevated GGT confirms hepatobiliary source, while normal GGT with elevated ALP indicates bone or other non-hepatic origin. 1

Step 1: Confirm the Tissue Source

Use GGT as the Primary Discriminator

• GGT is present in liver but absent in bone, making it the most practical first-line test to differentiate hepatic from skeletal ALP elevation 1
• Concurrent elevation of both GGT and ALP confirms hepatobiliary origin and indicates cholestasis 1
• Normal GGT with elevated ALP points toward bone disease or other non-hepatic sources (intestine, placenta) 1

When GGT Results Are Equivocal

• Order ALP isoenzyme fractionation (electrophoresis or immunoassay) to directly identify the tissue of origin when GGT results are inconclusive 1
• Fractionation separates liver ALP (band L), bone ALP, intestinal ALP, and placental ALP 2, 3

Step 2: Interpret Hepatobiliary ALP Elevation

Pattern Recognition for Cholestatic Disease

• Isolated ALP elevation (without aminotransferase elevation) strongly suggests cholestatic liver disease 4
• ALP elevation with concurrent bilirubin rise indicates biliary obstruction or impaired bilirubin uptake 4

Common Hepatobiliary Causes by Clinical Context

• Choledocholithiasis is the leading cause of extra-hepatic biliary obstruction 1
• Primary biliary cholangitis and primary sclerosing cholangitis cause persistent isolated hepatic ALP elevation in chronic cholestatic disease 1
• Drug-induced cholestasis is a frequent iatrogenic cause—always review all medications, supplements, and herbal products 1
• Infiltrative diseases (sarcoidosis, amyloidosis) may present with isolated ALP elevation 1
• Cirrhosis, chronic hepatitis, congestive heart failure, and ischemic cholangiopathy can produce modest ALP increases 5, 1

Imaging Algorithm for Hepatobiliary Source

• Begin with abdominal ultrasound as the first-line modality to detect biliary obstruction 1
• Proceed to MRCP if ALP remains elevated after negative ultrasound to evaluate for chronic cholestatic diseases 1

Step 3: Interpret Bone ALP Elevation

Common Bone Pathology Causes

• Paget's disease of bone produces marked ALP elevation and is a common skeletal disorder 1
• Bony metastases (especially prostate, breast, lung cancer) raise bone-specific ALP and carry prognostic significance 1
• Healing fractures cause transient ALP elevation during the reparative phase 1
• Osteomalacia (rare) can produce elevated ALP 6

Bone-Specific Testing

• Measure bone-specific ALP (B-ALP) when metastatic bone disease is suspected; elevated B-ALP serves as a prognostic marker 1
• Order bone scintigraphy or cross-sectional imaging (CT/MRI) when bone metastases are clinically suspected 1

Step 4: Recognize Physiologic and Special Populations

Physiologic Elevations

• Children and adolescents have elevated ALP due to rapid bone growth—use age- and sex-specific reference ranges 2, 7
• Pregnancy raises ALP via placental production—this is normal 1
• Post-menopausal women may exhibit higher ALP from osteoporosis-related bone turnover 1

Critical Pitfall in Infants

• In infants with parenteral nutrition-associated liver disease (PNALD), elevated total ALP predominantly reflects bone disease (metabolic bone disease), not liver disease, despite concurrent cholestasis 8
• Fractionated ALP in these infants shows markedly elevated bone-specific ALP with normal liver-specific ALP 8

Step 5: Address Special Clinical Scenarios

When Total ALP Is Normal but Clinical Suspicion Remains

• A normal total ALP does not rule out an abnormal isoenzyme pattern, particularly in children 2
• Consider fractionation if clinical context suggests occult liver or bone disease 2

Nonspecific Liver ALP Elevation

• Hepatic ALP isoenzyme elevation can be a nonspecific finding in patients without obvious liver disease 3
• Band L (liver ALP) may be elevated in conditions without clear hepatobiliary pathology, requiring clinical correlation 3

Assay Considerations

• Use identical assay conditions (buffer, pH, substrate) when comparing total ALP to fractionated ALP results, as different conditions yield different quantitative results 9
• Most serum ALP (>80%) derives from liver and bone; intestinal ALP contributes modestly 10

Critical Pitfalls to Avoid

• Do not assume all ALP elevations are hepatic—always confirm origin with GGT or isoenzyme testing, especially in post-menopausal women and patients with known bone disease 1
• Perform thorough medication review for drug-induced cholestasis, including over-the-counter supplements 1
• Use age- and sex-specific reference ranges—failure to do so leads to misinterpretation, particularly in children and adolescents 2, 7
• In infants with cholestasis, do not attribute elevated ALP solely to liver disease—fractionation often reveals predominant bone ALP elevation 8
• Persistently low ALP levels (hypophosphatasemia) warrant evaluation for hypophosphatasia and other genetic disorders 7